Crinetics Pharmaceuticals Inc annual net income for fiscal TTM was -$502 million, a decrease of 8.0% from -$465 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($502M) | ($465M) | ($298M) | ($215M) | ($160M) | ($107M) | ($73M) | ($50M) | ($27M) | ($9M) | ($6M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($121M) | ($128M) | ($123M) | ($130M) | ($116M) | ($97M) | ($81M) | ($77M) | ($74M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CRNX metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All CRNX financial statements → Interactive CRNX charts →
About TickerBase · Data methodology & sources · Privacy · Terms